Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

ASH Elects Three New Leaders to the Executive Committee

November 30, 2023

December 2023

Robert S. Negrin, MD Vice President Mary M. Horowitz, MD, MS Councillor H. Leighton Grimes, PhD Councillor in Basic Investigative Research

Robert S. Negrin, MD        Mary M. Horowitz, MD, MS   H. Leighton Grimes, PhD
Vice President                    Councillor                                Councillor in Basic Investigative Research

The American Society of Hematology (ASH) has announced the election of three new members to its Executive Committee for terms starting after the 65th ASH Annual Meeting and Exposition, taking place December 9-12, 2023, in San Diego.

Robert S. Negrin, MD, will serve a one-year term as vice president, followed by successive terms as president-elect and president. Mary M. Horowitz, MD, MS, and H. Leighton Grimes, PhD, will serve four-year terms as councillors. Dr. Grimes will serve as ASH’s first-ever councillor in basic investigative research, a designated position for a PhD (or equivalent) scientist to help ensure that the interests of the scientific community are appropriately represented on the Executive Committee.

“Drs. Negrin, Horowitz, and Grimes have demonstrated immense dedication to ASH, its members, and the field of hematology. Together, they represent the future of the Society and the field. I congratulate them on the results of the election, and I look forward to hearing the unique perspectives and insights they’ll bring to the Society,” said ASH President, Robert A. Brodsky, MD, of Johns Hopkins University School of Medicine in Baltimore. “Under their leadership, the Society will be well-​positioned to lead our field in education, cutting-​edge research, and advocacy on behalf of patients with blood disorders worldwide.”

Dr. Negrin is a professor of medicine at Stanford University in Stanford, California. As a distinguished physician-scientist, Dr. Negrin has made significant research contributions in the areas of hematopoietic cell transplantation, cellular immunology, and immune system regulation. He is also deeply committed to training the next generation of physicians and scientists.

Dr. Negrin has demonstrated a deep devotion to ASH’s mission through roughly 25 years of service on a range of ASH committees and working groups. An ASH member since 1998, Dr. Negrin most recently served as the founding editor-in-chief of Blood Advances, a position he held from 2016 to 2021.

“In this extraordinary time in hematology, I look forward to working with the Society to strengthen the hematology workforce, support innovative research, and promote access to existing and emerging therapies for patients with hematologic disorders. I am honored to have the opportunity to lead such a highly regarded society and serve the global hematology community,” said Dr. Negrin.

Dr. Horowitz is deputy director of the Medical College of Wisconsin Cancer Center in Milwaukee. Her research interests include hematopoietic cell transplantation, survivorship and quality of life, and the integration of real-world and clinical trial data. Dr. Horowitz has been a member of ASH since 1981. She chaired the Nominating Committee from 2019 to 2022 and was co-founder of the ASH-CIBMTR-ASTCT Minority Career Development Award, co-​developed by ASH in partnership with the Center for International Blood and Marrow Transplant Research and the American Society for Transplantation and Cellular Therapy.

Dr. Grimes is a professor in the Division of Immunobiology at Cincinnati Children’s Hospital Medical Center in Ohio. Throughout his career, he has conducted research in hematopoiesis, molecular biology, and molecular oncology, including mouse modeling of hematopoiesis, myelopoiesis, and marrow failure syndromes. His work focuses on myelodysplastic syndromes, severe congenital neutropenia, and acute myeloid leukemia. An active ASH member since 2001, Dr. Grimes has been a member of the Awards Committee, an ad hoc member of the Scientific Committee on Bone Marrow Failure, and chair of the Scientific Committee on Myeloid Biology.

Congratulations to the newest members of the ASH Executive Committee! Learn more about ASH leadership at hematology.org/about/governance.

Help Congress Shape Health Care and Hematology Policy!

The ASH Congressional Fellowship is a year-long opportunity for one ASH member to work in a congressional office on Capitol Hill in Washington, DC, for a full academic year to help shape health care and hematology policy.

Starting in September 2024 and ending in August 2025, the fellowship aims to provide education on the policymaking process, including Congress’ relationship to the hematology community, and an opportunity to educate congressional members and staff about hematology.

Being an ASH Congressional Fellow allows you to:

  • Educate congressional members and staff about hematology
  • Become part of a highly respected and widely recognized network of policy-savvy scientists
  • Gain hands-on policy experience in a challenging environment
  • Choose a congressional office to work in with the aid of the American Association for the Advancement of Science (AAAS)
  • Get paid at the GS-12 level and receive a stipend for moving expenses and health care

The deadline to submit an application is January 31, 2024. For more information and to apply, visit hematology.org/advocacy/congressional-​fellowship.

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
February 2025

Advertisement intended for health care professionals

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals